Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study.
Journal Information
Full Title: Ther Adv Drug Saf
Abbreviation: Ther Adv Drug Saf
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CF is a co-author of the National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018. All other authors declare no conflict of interest."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: FS is supported by the Australian Government Research Training Program (RTP) through a University of Wollongong Doctoral Scholarship. SCI receives funding through a Heart Foundation Future Leader Fellowship by the Heart Foundation of Australia [Ref: 102821]. CF receives funding through a Heart Foundation Postdoctoral Fellowship [Ref: 102168] from the Heart Foundation of Australia and a National Health and Medical Research Council Emerging Leadership Fellowship [APP 1196262]."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025